 |
Trial Information
Summary: Prostate Cancer - High Risk, Men Age 18 and Above, Infused Antibody Plus Hormone Therapy Prior to Prostatectomy, 4 Month Research StudyThis study is designed to test the safety and efficacy of an investigational infused monoclonal antibody plus hormone therapy in men with high risk prostate cancer prior to prostatectomy surgery. Based on current prostate cancer status, the patient must already be a candidate for prostatectomy surgery. The cost of the surgery is not paid for as part of the research study. The age range is 18 years and above. The research study lasts up to 4 months. Based on initial response, there may be an additional 3 month treatment period available following surgery.
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received. This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials. Trial listings updated: September 12, 2008 at 2:47:47 PM |
|
|
Patient Resources: [ Trial Listing
] [ Notification Services ] [ Drug
Directories ]
Copyright © 1995 - 2008, CenterWatch |
